Kyle Guse
Board Member
Cerenome, Inc. (CNSY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kyle Guse
Kyle Guse is recorded as Board Member at Cerenome, Inc. (CNSY). Kyle Guse was last confirmed as CFO at Atossa Therapeutics, Inc. (ATOS) in a filing dated March 30, 2023. Cerenome, Inc. reported in an 8-K filed April 18, 2025 that Kyle Guse was appointed director of the Board, effective April 18, 2025. The proxy statement of Atossa Therapeutics, Inc. reports total compensation of $1,171,631 for Kyle Guse in fiscal 2023, including a base salary of $248,358. Disclosed compensation is on record for 6 fiscal years.
“On April 18, 2025, the Board of Directors (the "Board") of Plus Therapeutics, Inc (the "Company") unanimously appointed Mr. Kyle Guse to serve as a director of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-01–present
-
Start not stated–2023-03-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cerenome, Inc.
Other people whose current roles at this company are on record from its filings.
- Marc H. Hedrick CEO, Board Member
- Richard J. Hawkins Chairman, Board Member
- Andrew J. Sims CFO
- Andrew Sims CFO
- An van Es-Johansson Board Member
- An van Es-Johansson, M.D. Board Member
- Greg B. Petersen Board Member
- Howard Clowes Board Member
- Ronald A. Andrews Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Atossa Therapeutics, Inc. (ATOS) | General Counsel and Secretary | $248,358 | $1,171,631 |
| 2022 | Atossa Therapeutics, Inc. (ATOS) | General Counsel and Secretary | $466,658 | $1,527,871 |
| 2021 | Atossa Therapeutics, Inc. (ATOS) | General Counsel and Secretary | $456,700 | $2,801,628 |
| 2020 | Atossa Therapeutics, Inc. (ATOS) | General Counsel and Secretary | $421,056 | $1,385,466 |
| 2019 | Atossa Therapeutics, Inc. (ATOS) | Chief Financial Officer, General Counsel and Secretary | $421,056 | $2,329,472 |
| 2018 | Atossa Therapeutics, Inc. (ATOS) | Chief Financial Officer, General Counsel and Secretary | $408,000 | $1,088,931 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.